Metabolize raised $3.2 million in seed financing to commercialize its Precision Metabolite technology and launch NATLEAN.
- Amount
- $3.2M
- Stage
- Seed
- Announced
- 15 October 2026
- Lead
- Astanor
- Other investors
- Maia Ventures, LongGame Venture, SOSV
- Use of funds
- Commercializing Precision Metabolite Technology, supporting product development, validation and manufacturing, and launching NATLEAN.
- Checked
- Announced by the company